DEC TIMOTHY C

CIK 00011940204 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001194020

Recent Transactions

50 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06+3,000→ 8,115 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2026-03-06−3,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2026-03-06−3,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06+3,000→ 9,682 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06$54.73/sh−1,450→ 8,232 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06$54.73/sh−1,433→ 6,682 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2026-02-28+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2026-02-28+3,000→ 3,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-25−2,500→ 2,500 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-25$50.69/sh−1,279→ 5,115 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-25+2,500→ 6,394 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−500→ 0 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−3,000→ 6,000 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24$50.86/sh−242→ 2,418 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+1,125→ 2,763 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24$50.86/sh−1,524→ 3,894 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24$51.35/sh−603→ 2,160 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+3,000→ 5,418 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−1,125→ 3,375 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+500→ 2,660 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-18+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2026-02-18+17,500→ 17,500 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-22$44.49/sh−11,780→ 1,246 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10$32.06/sh−955→ 12,681 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10$32.06/sh−1,062→ 11,836 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10+1,800→ 13,636 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-03-10−2,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-03-10−1,800→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10+2,000→ 12,898 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−1,587→ 12,228 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−276→ 13,815 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−1,330→ 10,898 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-02-28+1,800→ 1,800 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-02-28+2,000→ 2,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−2,500→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+2,500→ 14,091 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+3,000→ 11,591 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−3,000→ 9,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−500→ 500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+500→ 8,591 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+40,000→ 40,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−2,500→ 7,500 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−1,314→ 7,190 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+2,500→ 8,504 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-02-22+50,000→ 50,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22+12,000→ 12,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22−500→ 1,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+500→ 6,004 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-10-13−4,000→ 0 total

Companies

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov